All Title Author
Keywords Abstract


Sartans and angiotensin converting enzyme inhibitors: a duel between two leaders of pharmacotherapy of cardiovascular diseases

Full-Text   Cite this paper   Add to My Lib

Abstract:

Topical issues of cardiovascular disease pharmacotherapy influencing function of the renin-angiotensin-aldosterone system are discussed. Efficacy and safety of two major cardiovascular drug classes, angiotensin converting enzyme inhibitors and sartans, are compared. Data from evidence base of the both drug classes are presented.

Full-Text

comments powered by Disqus